Home

JAMES R GAVIN III

CIK 1220966 · President and CEO · last filed 2020-09-15

JAMES R GAVIN III is a President and CEO who has filed 106 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for BAX, was dated Sep 15, 2020. Across all open-market trades the lifetime net is −$5.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 76 SEC filings were submitted jointly with BAXTER INTERNATIONAL INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.13M

Companies

3

Total Filings

106

Lifetime Open-Market Net

-$5.33M

Filer Profile

Reported Address
BAXTER INTERNATIONAL INC
ONE BAXTER PARKWAY
DEERFIELD, IL 60015
Related Filers
BAXTER INTERNATIONAL INC — 76 joint filings, latest 2020-09-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BAX Director 43,618 $25.83 $1.13M -$5.10M 68 2020-09-15
Baxalta Inc (BXLT) Delisted Director 30,747 — — -$226.2K 4 2016-05-12
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted Director 4,580 — — -$10.0K 29 2012-05-24

Recent Filings

106 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-09-15 BAX Other (J) — $0 EDGAR
2020-08-05 BAX Mixed — -$719.1K EDGAR
2020-05-07 BAX Grant (A) +2,197 $0 EDGAR
2019-08-20 BAX Mixed — -$432.9K EDGAR
2019-07-10 BAX Grant (A) — $0 EDGAR
2019-05-15 BAX Grant (A) — $0 EDGAR
2019-05-09 BAX Grant (A) +2,412 $0 EDGAR
2019-01-16 BAX Grant (A) — $0 EDGAR
2018-11-19 BAX Grant (A) — $0 EDGAR
2018-08-13 BAX Grant (A) — $0 EDGAR
Showing 1–10 of 106
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.